(Q36198603)

12 August 2017

1 reference

title

Stereotactic radiosurgery with and without whole-brain radiotherapy for newly diagnosed brain metastases (English)

1 reference

12 August 2017

Simon S Lo

1

1 reference

12 August 2017

Eric L Chang

series ordinal

2

1 reference

12 August 2017

John H Suh

series ordinal

3

1 reference

12 August 2017

publication date

1 July 2005

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

12 August 2017

published in

1 reference

12 August 2017

volume

5

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

487-495

1 reference

Adjuvant treatment of brain metastases

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Intracranial recurrence of carcinoma after complete surgical resection of stage I, II, and III non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Central nervous system metastasis from breast carcinoma. Autopsy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Late solitary cerebral metastases from renal cell carcinoma: report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Brain metastases from colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

A randomized trial of surgery in the treatment of single metastases to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Radiosurgery for brain metastases: is whole brain radiotherapy necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Brain metastasis from melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Intracranial metastases from melanoma. Clinical features and treatment by accelerated fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Cerebral metastases from malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Brain metastasis in hypernephroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Palliative radiotherapy for brain metastases in renal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

External radiation of brain metastases from renal carcinoma: a retrospective study of 119 patients from the M. D. Anderson Cancer Center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Gamma surgery for intracranial metastases from renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Gamma-knife radiosurgery for brain metastases of renal cell carcinoma: results in 23 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Gamma surgery for melanoma metastases in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Club de Cancérologie Cutanée

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Response of intracranial melanoma metastases to stereotactic radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.487

21 January 2018

Identifiers

DOI

10.1586/14737175.5.4.487

1 reference

release_6pssk23chjcohoh37ndbvf6nri

12 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6pssk23chjcohoh37ndbvf6nri

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference